Login to Your Account



Search

Search results

Clinic roundup

Questcor Pharmaceuticals Inc. , of Anaheim Hills, Calif., said that results from an investigator-initiated clinical study showed that H.P. Acthar Gel (repository corticotropin) could be a potentially useful therapy for inducing remission of proteinur ...

BioWorld Today - Staff - 2014-04-21 23:00 - 0 comments - 0 attachments

Clinic roundup

Stemcells Inc. , of Newark, Calif., completed enrollment of the phase I/II trial in spinal cord injury, testing the safety and preliminary efficacy of the HuCNS-SC human neural stem cells. The trial enrolled 12 subjects with chest-level injury to t ...

BioWorld Today - Staff - 2014-04-17 23:00 - 0 comments - 0 attachments

Clinic roundup

Cleveland Biolabs Inc. , of Buffalo, New York, said it successfully evaluated CBL0102 (quinacrine), an orally administered small molecule, for maximum tolerated dose and dose-limiting toxicities in patients with advanced cancers during a phase I tria ...

BioWorld Today - Staff - 2014-04-16 23:00 - 0 comments - 0 attachments

Clinic roundup

Akebia Therapeutics Inc. , of Cambridge, Mass., said it completed enrollment in its ongoing 200-patient phase IIb study of AKB-6548, a hypoxia-inducible factor prolyl hydroxylase inhibitor, for the treatment of anemia associated with chronic kidney d ...

BioWorld Today - Staff - 2014-04-15 23:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Abbvie Inc. , of North Chicago, initiated a global phase III trial evaluating the safety and efficacy of veliparib (ABT-888) in patients with previously untreated locally advanced or metastatic squamous non-small-cell lung cancer (NSCLC). (B ...

BioWorld Today - Staff - 2014-04-15 23:00 - 0 comments - 0 attachments

Clinic roundup

Intercept Pharmaceuticals Inc. , of New York, presented results from the phase III POISE trial of obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBC) at the International Liver Congress of the European Association of the Study ...

BioWorld Today - Staff - 2014-04-14 23:00 - 0 comments - 0 attachments

Clinic roundup

Dendreon Corp. , of Seattle, reported that preliminary data from a long-term analysis of the phase II STAND study suggested tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given following androgen d ...

BioWorld Today - Staff - 2014-04-13 23:00 - 0 comments - 0 attachments

Clinic roundup

Affimed Therapeutics AG , of Heidelberg, Germany, said results from a phase I trial of AFM13, its monotherapy for the treatment of patients with advanced relapsing/refractory Hodgkin lymphoma, confirmed the drug's safety in 28 heavily pretreated pati ...

BioWorld Today - Staff - 2014-04-10 23:00 - 0 comments - 0 attachments

Clinic roundup

Aegerion Pharmaceuticals Inc. , of Cambridge, Mass., said patient enrollment was initiated in Japan in a phase III trial of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in Japanese patients with homozygous ...

BioWorld Today - Staff - 2014-04-09 23:00 - 0 comments - 0 attachments

Clinic roundup

Oncolytics Biotech Inc. , of Calgary, Alberta, reported additional data from its phase III REO 018 study testing Reolysin in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-naïve head and nec ...

BioWorld Today - Staff - 2014-04-08 23:00 - 0 comments - 0 attachments